Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth
- 15 April 1975
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 15 (4), 640-650
- https://doi.org/10.1002/ijc.2910150413
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Development of Specific Cell-dependent Antibody During Growth of a Syngeneic Rat SarcomaBritish Journal of Cancer, 1974
- Radioimmunoassay of Tumour Specific Transplantation Antigen of a Chemically Induced Rat Sarcoma: Circulating Soluble Tumour Antigen in Tumour BearersBritish Journal of Cancer, 1973
- Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractionsInternational Journal of Cancer, 1973
- Detection of Circulating Hepatoma D23 Antigen and Immune Complexes in Tumour Bearer SerumBritish Journal of Cancer, 1973
- Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigenInternational Journal of Cancer, 1973
- Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour statusInternational Journal of Cancer, 1973
- Immunological Aspects Of Chemical CarcinogenesisAdvances in Cancer Research, 1973
- Blocking of Lymphocyte-mediated Cytotoxicity for Rat Hepatoma Cells by Tumour-specific Antigen-Antibody ComplexesNature New Biology, 1972
- Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytesBiochemical Journal, 1971
- Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.British Journal of Cancer, 1967